Ys Biopharma Co Stock Probability of Future Stock Price Finishing Over 0.94

YS Stock   0.94  0.09  10.59%   
YS Biopharma's future price is the expected price of YS Biopharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of YS Biopharma Co performance during a given time horizon utilizing its historical volatility. Check out YS Biopharma Backtesting, YS Biopharma Valuation, YS Biopharma Correlation, YS Biopharma Hype Analysis, YS Biopharma Volatility, YS Biopharma History as well as YS Biopharma Performance.
  
At this time, YS Biopharma's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 1.33 in 2024, whereas Price Earnings Ratio is likely to drop (6.64) in 2024. Please specify YS Biopharma's target price for which you would like YS Biopharma odds to be computed.

YS Biopharma Target Price Odds to finish over 0.94

The tendency of YS Biopharma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.94 90 days 0.94 
roughly 2.28
Based on a normal probability distribution, the odds of YS Biopharma to move above the current price in 90 days from now is roughly 2.28 (This YS Biopharma Co probability density function shows the probability of YS Biopharma Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon YS Biopharma Co has a beta of -0.23. This entails as returns on the benchmark increase, returns on holding YS Biopharma are expected to decrease at a much lower rate. During a bear market, however, YS Biopharma Co is likely to outperform the market. Moreover YS Biopharma Co has an alpha of 1.0641, implying that it can generate a 1.06 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   YS Biopharma Price Density   
       Price  

Predictive Modules for YS Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as YS Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of YS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.050.947.52
Details
Intrinsic
Valuation
LowRealHigh
0.030.677.25
Details
Naive
Forecast
LowNextHigh
0.020.977.56
Details
1 Analysts
Consensus
LowTargetHigh
4.645.105.66
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as YS Biopharma. Your research has to be compared to or analyzed against YS Biopharma's peers to derive any actionable benefits. When done correctly, YS Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in YS Biopharma.

YS Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. YS Biopharma is not an exception. The market had few large corrections towards the YS Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold YS Biopharma Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of YS Biopharma within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
1.06
β
Beta against NYSE Composite-0.23
σ
Overall volatility
0.18
Ir
Information ratio 0.16

YS Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of YS Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for YS Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
YS Biopharma is way too risky over 90 days horizon
YS Biopharma has some characteristics of a very speculative penny stock
YS Biopharma appears to be risky and price may revert if volatility continues
YS Biopharma has high likelihood to experience some financial distress in the next 2 years
The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0.
YS Biopharma generates negative cash flow from operations
About 81.0% of the company outstanding shares are owned by insiders
Latest headline from news.google.com: YS Biopharma Set to Announce Quarterly Earnings on Friday - MarketBeat

YS Biopharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of YS Biopharma Stock often depends not only on the future outlook of the current and potential YS Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. YS Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding93.1 M
Cash And Short Term Investments370.1 M

YS Biopharma Technical Analysis

YS Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. YS Biopharma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of YS Biopharma Co. In general, you should focus on analyzing YS Biopharma Stock price patterns and their correlations with different microeconomic environments and drivers.

YS Biopharma Predictive Forecast Models

YS Biopharma's time-series forecasting models is one of many YS Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary YS Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about YS Biopharma

Checking the ongoing alerts about YS Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for YS Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
YS Biopharma is way too risky over 90 days horizon
YS Biopharma has some characteristics of a very speculative penny stock
YS Biopharma appears to be risky and price may revert if volatility continues
YS Biopharma has high likelihood to experience some financial distress in the next 2 years
The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0.
YS Biopharma generates negative cash flow from operations
About 81.0% of the company outstanding shares are owned by insiders
Latest headline from news.google.com: YS Biopharma Set to Announce Quarterly Earnings on Friday - MarketBeat
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YS Biopharma Stock, refer to the following important reports:

Complementary Tools for YS Biopharma Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.56)
Revenue Per Share
5.159
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.12)
Return On Equity
(0.62)
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.